Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
NAPA Duckhorn Portfolio Inc
NDACU Nightdragon Acquisition Corp
EMPYF Empress Royalty Corp
CGC Canopy Growth Corp
FMCB Farmers & Merchants Bancorp
GM General Motors Co
CBMB CBM Bancorp Inc
SCHW Charles Schwab Corp
WSC Willscot Mobile Mini Holdings Corp
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company's portfolio of products and pipeline of investigational drugs includes treatments for HIV/acquired immune deficiency syndrome (AIDS), COVID-19, liver diseases, hematology/oncology/cell therapy and other. Its products for HIV/AIDS patients include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada and Atripla. It offers Veklury to patients with COVID-19. The Company's products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Viread and Vosevi. Its products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy and Zydelig. Other products include Letairis, Ranexa and AmBisome. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. The Company operates in more than 335 countries worldwide.

Closing Price
$69.56
Day's Change
-0.11 (-0.16%)
Bid
--
Ask
--
B/A Size
--
Day's High
70.46
Day's Low
69.31
Volume
(Average)
Volume:
8,328,150

10-day average volume:
8,695,873
8,328,150
  • Prev Close
    69.67
  • Today's Open
    70.00
  • Day's Range
    69.31-70.46
  • Avg Vol (10-day)
    8.7M
  • Last (time)
    4:00p ET 12/03/21
  • Last (size)
    49
  • 52-Wk Range
    56.56 - 73.34
    LowHigh
  • (12/31/20 - 08/18/21)
    5.15%
  • 19.3%
  • Market Cap
    87.3B
  • Shares Outstanding
    1.3B
  • 5.84
  • 11.92x
  • $2.84/4.08%
  • Ex-dividend Date
    12/14/21
  • Dividend Pay Date
    12/30/21
  • 0.4
  • 79.53
  • (% of float 11/15/21)
    1.85

Latest News

December 03, 2021
4:55 pm ET
MarketWatch
December 02, 2021
4:56 pm ET
MarketWatch
December 01, 2021
4:55 pm ET
MarketWatch
November 30, 2021
4:55 pm ET
MarketWatch
November 29, 2021
4:55 pm ET
MarketWatch
9:00 am ET
BusinessWire
8:30 am ET
BusinessWire
November 24, 2021
4:55 pm ET
MarketWatch
11:21 am ET
Zacks
9:32 am ET
PR Newswire
November 23, 2021
4:56 pm ET
MarketWatch
8:30 am ET
BusinessWire
November 22, 2021
4:56 pm ET
MarketWatch
November 19, 2021
4:55 pm ET
MarketWatch
8:53 am ET
MarketWatch
8:00 am ET
BusinessWire
November 18, 2021
4:56 pm ET
MarketWatch
4:05 pm ET
BusinessWire
7:38 am ET
MarketWatch
7:29 am ET
MarketWatch
7:29 am ET
MarketWatch
7:00 am ET
BusinessWire
7:00 am ET
BusinessWire
November 17, 2021
4:55 pm ET
MarketWatch
November 15, 2021
4:55 pm ET
MarketWatch
November 12, 2021
4:55 pm ET
MarketWatch
10:45 am ET
PR Newswire
November 11, 2021
4:55 pm ET
MarketWatch
November 10, 2021
7:05 pm ET
PR Newswire
7:00 pm ET
BusinessWire
4:55 pm ET
MarketWatch
November 09, 2021
4:56 pm ET
MarketWatch
10:00 am ET
BusinessWire
November 08, 2021
4:55 pm ET
MarketWatch
November 05, 2021
4:56 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.